SRC and neoplasm: We found that the mice injected with TPC-1/shRNA-SRC-1 cells displayed delayed tumor growth (Figure 5A) and smaller the tumor volumes (Figure 5B) when compared with the mice injected with TPC-1/shRNA-NC cells.